Is Prana (the AI primary care startup) profitable in 2026?

No. As of July 22, 2026, Y Combinator's own directory still lists Prana as 'beta with early users' with no revenue, customer counts, or logos disclosed. The company is pre-revenue and has a 4-person team, five-plus months after its February 2026 launch.

Could AI like ChatGPT or Claude replace Prana's business?

Prana's entire product IS an AI bet on replacing primary-care workflows, but its only barrier against raw frontier models is state medical licensing plus human sign-off, a seal shared by every rival (Clara, Doctronic, Certuma) and by incumbents. No proprietary moat has been publicly reported as of July 2026.

Who is Prana's biggest competitor?

Doctronic, a New York AI-doctor startup, raised a $40M Series B in March 2026 (total $65M) and is piloting autonomous prescription renewal authority in Utah, with independent MDs agreeing with its non-escalated calls 91% of the time, per Forbes reporting on July 24, 2026.

Who owns and founded Prana?

Prana is a private company backed by Y Combinator (W26 batch). YC's official launch page names Meer Patel (CEO), Vishvam Rawal (CTO), and Sanjit Menon (CHO) as founders, per the February 10, 2026 Launch YC post tied to the pranadoc.com domain.

What does Prana's product actually do as of mid-2026?

As of June 17, 2026, pranadoc.com offered a free AI-doctor chat for symptom guidance plus paid $39 video visits with a licensed physician who can send prescriptions to a pharmacy, a simpler offer than the February 2026 pitch of continuous wearable and EHR monitoring for 'clinical drift.'

Has Prana raised meaningful funding compared to rivals?

No confirmed institutional round beyond standard Y Combinator batch investment has been publicly disclosed for Prana as of July 2026. By contrast, competitor Doctronic has raised $65M total and Certuma raised a $10M seed at a $60M valuation, both reported July 24, 2026.

YC Winter 2026 · United States

Prana

AI chat app offering symptom checks plus paid $39 doctor video visits.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q3 2026 · Every call on the record Checkpoint: Decision point on returning to continuous monitoring versus staying with the $39 symptom-chat model

The call

Prana dropped its harder, more defensible monitoring idea for a generic chat-plus-visit product that free AI tools and bigger telehealth firms can already match.

Prana lets people chat with AI about symptoms and then talk to a real doctor for $39 per visit. The company started with a smarter idea: using data from smartwatches and medical records to help employers save money on healthcare costs. But Prana dropped that plan and switched to being just another symptom checker, which any AI chatbot like ChatGPT could copy tomorrow. The only thing stopping ChatGPT from doing this now is that doctors need licenses in each state, but Prana's competitors (Clara, Doctronic, Certuma) can get those same licenses just as easily. If Prana gets funding in the next few months without clear evidence that employers are signing up, it will mean the company gave up on its defensible advantage for good.

Why

AI pressure: ChatGPT and Claude. General chatbots already answer symptom questions for free, undercutting Prana's core chat before the $39 visit fee even applies. Could AI do the core job? Yes, likely.

Bigger players: Teladoc Health and Amazon One Medical. Both already run virtual visits and symptom triage at huge scale, and could copy Prana's chat-plus-visit model without much extra work. Could a giant copy it? Yes, easily.

What protects it. Prana is so small and unnoticed, with no employer deals or regulatory approvals, that bigger players have no reason to target it yet.

What would change this call

Prana discloses a named self-insured employer pilot within 6-9 months. Would show it regained the monitoring/employer wedge instead of drifting into commodity chat.
Prana raises a Series A with stated use of funds. Would show whether new capital targets regulatory approval or just sales/marketing of the commodity visit.
Prana pursues or wins a state-level regulatory approval like Doctronic's Utah pilot. Would show it is building a defensible regulatory moat rather than competing on price alone.

Key numbers

4 employees, unchanged Jan through Jul 2026 (2026-07-22)
Doctronic raised $65M total, incl $40M Series B (2026-07-24)
Clara founders grew Circle Medical to $100M revenue (2026-05-14)

Named risks

Abandoned only defensible wedge (monitoring/employer channel) for commodity symptom-checker model by mid-2026. Severity: high
No proprietary moat; licensing/liability layer shared by all competitors and incumbents. Severity: high
Severely underfunded vs rivals (Doctronic $65M, Certuma $60M valuation) as of 2026-07-24. Severity: medium
Regulatory scrutiny of AI-autonomous prescribing could tighten rules for entire category within 6 months. Severity: medium
4-person team with no disclosed traction 5+ months post-launch, pre-revenue. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Doctronic	losing to	Doctronic raised $65M total and got a Utah autonomous-prescribing pilot by 2026-07-24; Prana has no such milestone
Clara	losing to	Clara launched 2026-05-14 with founders who grew Circle Medical to $100M revenue (vendor-claimed), closer positioning against raw AI models
Certuma	losing to	Certuma raised $10M seed at $60M valuation by 2026-07-24, outpacing Prana's undisclosed funding
Teladoc Health / Amazon One Medical	contesting	Incumbents could bolt on same AI-doctor funnel since licensing model is not proprietary to Prana
Nori	contesting	Smaller YC-backed rival (~3 employees) pursuing coaching angle rather than diagnostic, as of 2026-07-04

Questions people ask

Is Prana (the AI primary care startup) profitable in 2026?: No. As of July 22, 2026, Y Combinator's own directory still lists Prana as 'beta with early users' with no revenue, customer counts, or logos disclosed. The company is pre-revenue and has a 4-person team, five-plus months after its February 2026 launch.
Could AI like ChatGPT or Claude replace Prana's business?: Prana's entire product IS an AI bet on replacing primary-care workflows, but its only barrier against raw frontier models is state medical licensing plus human sign-off, a seal shared by every rival (Clara, Doctronic, Certuma) and by incumbents. No proprietary moat has been publicly reported as of July 2026.
Who is Prana's biggest competitor?: Doctronic, a New York AI-doctor startup, raised a $40M Series B in March 2026 (total $65M) and is piloting autonomous prescription renewal authority in Utah, with independent MDs agreeing with its non-escalated calls 91% of the time, per Forbes reporting on July 24, 2026.
Who owns and founded Prana?: Prana is a private company backed by Y Combinator (W26 batch). YC's official launch page names Meer Patel (CEO), Vishvam Rawal (CTO), and Sanjit Menon (CHO) as founders, per the February 10, 2026 Launch YC post tied to the pranadoc.com domain.
What does Prana's product actually do as of mid-2026?: As of June 17, 2026, pranadoc.com offered a free AI-doctor chat for symptom guidance plus paid $39 video visits with a licensed physician who can send prescriptions to a pharmacy, a simpler offer than the February 2026 pitch of continuous wearable and EHR monitoring for 'clinical drift.'
Has Prana raised meaningful funding compared to rivals?: No confirmed institutional round beyond standard Y Combinator batch investment has been publicly disclosed for Prana as of July 2026. By contrast, competitor Doctronic has raised $65M total and Certuma raised a $10M seed at a $60M valuation, both reported July 24, 2026.

Timeline

2026-07-24Forbes reports Doctronic's Utah autonomous-prescribing pilot and Certuma's $10M seed at $60M valuation
2026-07-22YC directory still lists Prana at 4 employees, beta status, no revenue disclosed
2026-06-17pranadoc.com shows product shift to free AI chat plus $39 physician video visits
2026-05-14Rival Clara launches on YC, founded by team that grew Circle Medical to $100M revenue (vendor-claimed)
2026-03Doctronic closes $40M Series B (Abstract, Lightspeed), total funding reaches $65M
2026-02-19Hiretop profile describes Prana as 'The AI Doctor That Never Sleeps'
2026-02-10Prana launches on YC with continuous EHR plus wearable monitoring pitch, seeks employer pilots
2025Prana founded by Meer Patel, Vishvam Rawal, and Sanjit Menon

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

CellType OctaPulse The Token Company